BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

190 related articles for article (PubMed ID: 36971272)

  • 1. Diagnostic performance of magnetic resonance imaging in preoperative local staging of rectal cancer after neoadjuvant chemoradiotherapy.
    Çelik H; Barlık F; Sökmen S; Terzi C; Canda AE; Sağol Ö; Sarıoğlu S; Ünlü M; Bilkay Görken İ; Arıcan Alıcıkuş Z; Öztop İ
    Diagn Interv Radiol; 2023 Mar; 29(2):219-227. PubMed ID: 36971272
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prediction of pathologic staging with magnetic resonance imaging after preoperative chemoradiotherapy in rectal cancer: pooled analysis of KROG 10-01 and 11-02.
    Lee JH; Jang HS; Kim JG; Lee MA; Kim DY; Kim TH; Oh JH; Park SC; Kim SY; Baek JY; Park HC; Kim HC; Nam TK; Chie EK; Jung JH; Oh ST
    Radiother Oncol; 2014 Oct; 113(1):18-23. PubMed ID: 25245559
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Diagnostic accuracy of MRI in assessing tumor regression and identifying complete response in patients with locally advanced rectal cancer after neoadjuvant treatment.
    Aker M; Boone D; Chandramohan A; Sizer B; Motson R; Arulampalam T
    Abdom Radiol (NY); 2018 Dec; 43(12):3213-3219. PubMed ID: 29767284
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Diagnostic performance of MRI for prediction of candidates for local excision of rectal cancer (ypT0-1N0) after neoadjuvant chemoradiation therapy.
    Kim JG; Song KD; Kim SH; Kim HC; Huh JW
    J Magn Reson Imaging; 2016 Aug; 44(2):471-7. PubMed ID: 26800999
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Endoscopy and magnetic resonance imaging-based prediction of ypT stage in patients with rectal cancer who received chemoradiotherapy: Results from a prospective study of 110 patients.
    Cho MS; Kim H; Han YD; Hur H; Min BS; Baik SH; Cheon JH; Lim JS; Lee KY; Kim NK
    Medicine (Baltimore); 2019 Aug; 98(35):e16614. PubMed ID: 31464897
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Diagnostic performance of magnetic resonance to assess treatment response after neoadjuvant therapy in patients with locally advanced rectal cancer.
    Nahas SC; Nahas CSR; Cama GM; de Azambuja RL; Horvat N; Marques CFS; Menezes MR; Junior UR; Cecconello I
    Abdom Radiol (NY); 2019 Nov; 44(11):3632-3640. PubMed ID: 30663025
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Evaluation of a multiparametric MRI scoring system for histopathologic treatment response following preoperative chemoradiotherapy for rectal cancer.
    Khwaja SA; Thipphavong S; Kirsch R; Menezes RJ; Kennedy ED; Brierley JD; Jhaveri KS
    Eur J Radiol; 2021 May; 138():109628. PubMed ID: 33721764
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Diagnostic accuracy of 3.0T high-resolution MRI for assessment mesorectal lymph node metastases in patients with rectal cancer].
    Chen Y; Yang X; Lu B; Xiao X; Zhuang X; Yu S
    Zhonghua Wei Chang Wai Ke Za Zhi; 2018 Jul; 21(7):786-792. PubMed ID: 30051447
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The role of readout-segmented echo-planar imaging-based diffusion-weighted imaging in evaluating tumor response of locally advanced rectal cancer after neoadjuvant chemoradiotherapy.
    Yang L; Xia C; Liu D; Fang X; Pan X; Ma L; Wu B
    Acta Radiol; 2020 Sep; 61(9):1155-1164. PubMed ID: 31924105
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Nodal staging in the rectal cancer follow-up MRI after chemoradiotherapy: use of morphology, size, and diffusion criteria.
    Fornell-Perez R; Perez-Alonso E; Aleman-Flores P; Lozano-Rodriguez A; Loro-Ferrer JF
    Clin Radiol; 2020 Feb; 75(2):100-107. PubMed ID: 31515052
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Locally advanced rectal cancer: qualitative and quantitative evaluation of diffusion-weighted magnetic resonance imaging in restaging after neoadjuvant chemo-radiotherapy.
    Napoletano M; Mazzucca D; Prosperi E; Aisa MC; Lupattelli M; Aristei C; Scialpi M
    Abdom Radiol (NY); 2019 Nov; 44(11):3664-3673. PubMed ID: 31004202
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Usefulness of Restaging Pelvis Magnetic Resonance Imaging After Neoadjuvant Concurrent Chemoradiotherapy in Patients With Locally Advanced Rectal Cancer.
    Fahmawi Y; Smith C; Grimm L; Khullar S; Rider P; Hunter J; Iliff G; Mneimneh W; Roveda K; Wang B; Prodduturvar P; Alkharabsheh O; McCormick B; Mizrahi M; Khushman M
    Clin Colorectal Cancer; 2020 Dec; 19(4):e281-e287. PubMed ID: 32694005
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Evaluating the incidence of pathological complete response in current international rectal cancer practice: the barriers to widespread safe deferral of surgery.
    2017 European Society of Coloproctology (ESCP) collaborating group
    Colorectal Dis; 2018 Sep; 20 Suppl 6():58-68. PubMed ID: 30255641
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Magnetic resonance imaging for assessment of rectal cancer nodes after chemoradiotherapy: A single center experience.
    Barbaro B; Carafa MRP; Minordi LM; Testa P; Tatulli G; Carano D; Fiorillo C; Chiloiro G; Romano A; Valentini V; Gambacorta MA
    Radiother Oncol; 2024 Apr; 193():110124. PubMed ID: 38309586
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Diffusion-weighted MRI and MR- volumetry--in the evaluation of tumor response after preoperative chemoradiotherapy in patients with locally advanced rectal cancer.
    Birlik B; Obuz F; Elibol FD; Celik AO; Sokmen S; Terzi C; Sagol O; Sarioglu S; Gorken I; Oztop I
    Magn Reson Imaging; 2015 Feb; 33(2):201-12. PubMed ID: 25460330
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The split scar sign as an indicator of sustained complete response after neoadjuvant therapy in rectal cancer.
    Santiago I; Barata M; Figueiredo N; Parés O; Henriques V; Galzerano A; Carvalho C; Matos C; Heald RJ
    Eur Radiol; 2020 Jan; 30(1):224-238. PubMed ID: 31350587
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Contrast-enhanced MRI for T Restaging of Locally Advanced Rectal Cancer Following Neoadjuvant Chemotherapy and Radiation Therapy.
    Lu QY; Guan Z; Zhang XY; Li XT; Sun RJ; Li QY; Sun YS
    Radiology; 2022 Nov; 305(2):364-372. PubMed ID: 35852424
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The accuracy of endorectal ultrasonography and high-resolution magnetic resonance imaging for restaging rectal cancer after neoadjuvant chemoradiotherapy.
    Cote A; Florin FG; Mois E; Elisei R; Badea R; Mare C; Hajjar NA; Iancu C; Lebovici A
    Ann Ital Chir; 2018; 89():168-176. PubMed ID: 29848812
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Value of diffusion-weighted MRI and apparent diffusion coefficient measurements for predicting the response of locally advanced rectal cancer to neoadjuvant chemoradiotherapy.
    Iannicelli E; Di Pietropaolo M; Pilozzi E; Osti MF; Valentino M; Masoni L; Ferri M
    Abdom Radiol (NY); 2016 Oct; 41(10):1906-17. PubMed ID: 27323759
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Locally advanced rectal cancer: added value of diffusion-weighted MR imaging for predicting tumor clearance of the mesorectal fascia after neoadjuvant chemotherapy and radiation therapy.
    Park MJ; Kim SH; Lee SJ; Jang KM; Rhim H
    Radiology; 2011 Sep; 260(3):771-80. PubMed ID: 21846762
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.